ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Senate Approves FY08 Labor-HHS Appropriations.

October 26, 2007

In Brief: 163 PIs Hold Both Contracts, Grants; Hopkins Scientists Questions Retrospective Diet Studies

August 27, 1976

Adding Ultrasound Revealed More Breast Cancers In Study

May 30, 2008

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012